1- Department of Hematology and Oncology, Ardabil University of Medical Sciences, Ardabil, Iran 2- BS in Laboratory Sciences, Ardabil University of Medical Sciences, Ardabil. Iran , mabodazad@gmail.com 3- General Practitioner, Ardabil University of Medical Sciences, Ardabil. Iran 4- BS in Anesthesiology, urmia University of Medical Sciences, urmia, Iran
Abstract: (7352 Views)
Background: Beta thalassemia is a common genetic disease in humans. This study aimed to assess various aspects of quality of life in patients with thalassemia major referred to Buali hospital in 2012-13.
Materials and methods: This cross-sectional analytical study was conducted on 40 patients with thalassemia major. Data were analyzed by statistical software SPSS V16 using Chi-square and t-test. The significance level was set at less than 0.05.
Results: 40 patients with mean (± standard deviation) age of 20.38±7.13 years were studied. 50% of patients were in the age range of 30-21 years. 22 patients (55%) were male. The mean age of the diagnosis was 7.5±1.4 months. Mean age of starting deferoxamine was 5.93±4.37 years. Data analysis revealed no significant relationship between age (P=0.246), gender (P= 0.259) and location of residency (P = 0.753) with quality of life.
Conclusion: There were the highest quality within the role of the physical evidence and lowest quality in the area of patient's general health. Quality of caring was appropriate.
Keywords: Beta-thalassemia major, Care, Quality of life, Bu Ali Hospital.
vafaei M, Azad M, Shiargar P, Kazemi Haki B. Quality of life in patients with thalassemia major referred to Ardabil Buali Hospital in 2012-13 . MEDICAL SCIENCES 2015; 25 (4) :305-310 URL: http://tmuj.iautmu.ac.ir/article-1-1029-en.html